Patton Albertson Miller Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $305K | Sell |
5,289
-137
| -3% | -$7.87K | 0.03% | 183 |
|
|
2026
Q1 | $329K | Sell |
5,426
-65
| -1% | -$3.79K | 0.04% | 182 |
|
|
2025
Q4 | $296K | Buy |
5,491
+150
| +3% | +$7.22K | 0.03% | 187 |
|
|
2025
Q3 | $241K | Sell |
5,341
-233
| -4% | -$10.9K | 0.03% | 193 |
|
|
2025
Q2 | $258K | Buy |
5,574
+824
| +17% | +$40.4K | 0.03% | 191 |
|
|
2025
Q1 | $290K | Hold |
4,750
| – | – | 0.04% | 181 |
|
|
2024
Q4 | $269K | Hold |
4,750
| – | – | 0.04% | 189 |
|
|
2024
Q3 | $246K | Buy |
+4,750
| New | +$223K | 0.03% | 195 |
|
|
2024
Q2 | – | Sell |
-6,120
| Closed | -$332K | – | 207 |
|
|
2024
Q1 | $332K | Sell |
6,120
-981
| -14% | -$50K | 0.05% | 163 |
|
|
2023
Q4 | $364K | Sell |
7,101
-1,112
| -14% | -$58.4K | 0.06% | 158 |
|
|
2023
Q3 | $477K | Sell |
8,213
-225
| -3% | -$13.8K | 0.09% | 148 |
|
|
2023
Q2 | $540K | Sell |
8,438
-1,293
| -13% | -$86.7K | 0.1% | 146 |
|
|
2023
Q1 | $674K | Sell |
9,731
-114
| -1% | -$8.04K | 0.12% | 142 |
|
|
2022
Q4 | $708K | Sell |
9,845
-160
| -2% | -$12.1K | 0.13% | 138 |
|
|
2022
Q3 | $711K | Buy |
10,005
+273
| +3% | +$19.8K | 0.15% | 133 |
|
|
2022
Q2 | $749K | Sell |
9,732
-158
| -2% | -$12K | 0.15% | 137 |
|
|
2022
Q1 | $722K | Sell |
9,890
-710
| -7% | -$47.7K | 0.12% | 154 |
|
|
2021
Q4 | $661K | Sell |
10,600
-640
| -6% | -$37.5K | 0.11% | 159 |
|
|
2021
Q3 | $665K | Buy |
11,240
+2,670
| +31% | +$176K | 0.13% | 153 |
|
|
2021
Q2 | $573K | Sell |
8,570
-200
| -2% | -$13K | 0.13% | 132 |
|
|
2021
Q1 | $554K | Sell |
8,770
-65
| -0.7% | -$4.04K | 0.13% | 133 |
|
|
2020
Q4 | $525K | Sell |
8,835
-210
| -2% | -$12.9K | 0.12% | 139 |
|
|
2020
Q3 | $545K | Sell |
9,045
-180
| -2% | -$10.8K | 0.15% | 129 |
|
|
2020
Q2 | $542K | Hold |
9,225
| – | – | 0.16% | 135 |
|
|
2020
Q1 | $514K | Sell |
9,225
-479
| -5% | -$29.3K | 0.17% | 133 |
|
|
2019
Q4 | $623K | Sell |
9,704
-258
| -3% | -$14.8K | 0.16% | 135 |
|
|
2019
Q3 | $505K | Sell |
9,962
-633
| -6% | -$29.8K | 0.14% | 154 |
|
|
2019
Q2 | $501K | Buy |
+10,595
| New | +$494K | 0.14% | 150 |
|
|
2018
Q4 | – | Sell |
-1,211
| Closed | -$59K | – | 139 |
|
|
2018
Q3 | $59K | Buy |
+1,211
| New | +$71.9K | 0.03% | 163 |
|
|
2016
Q1 | – | Sell |
-2,968
| Closed | -$204K | – | 121 |
|
|
2015
Q4 | $204K | Buy |
+2,968
| New | +$196K | 0.1% | 119 |
|
|
2015
Q3 | – | Sell |
-3,246
| Closed | -$216K | – | 115 |
|
|
2015
Q2 | $216K | Sell |
3,246
-3
| -0.1% | -$198 | 0.09% | 120 |
|
|
2015
Q1 | $210K | Buy |
+3,249
| New | +$203K | 0.09% | 135 |
|
Other funds holding BMY
LMFP
AIM
FWIA
DLA
Patton Albertson Miller Group's BMY Position: Q2 2026 in Review
Patton Albertson Miller Group reduced its Bristol-Myers Squibb (BMY) stake by 2.5% in Q2 2026, selling an estimated $7.87K and leaving 5,289 shares worth $305K. The position accounts for 0.03% of the portfolio, ranked #183.
Patton Albertson Miller Group first reported a position in BMY in Q1 2015 and has held it in 32 quarters since. The position peaked at $749K in Q2 2022. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Patton Albertson Miller Group held 5,289 shares of Bristol-Myers Squibb worth $305K as of Q2 2026.
- Patton Albertson Miller Group sold 137 Bristol-Myers Squibb shares in Q2 2026, an estimated $7.87K.
- Bristol-Myers Squibb made up 0.03% of Patton Albertson Miller Group's portfolio in Q2 2026, its #183 holding.
- Patton Albertson Miller Group first reported a position in Bristol-Myers Squibb in Q1 2015 and has held it in 32 quarters since.
- Patton Albertson Miller Group's Bristol-Myers Squibb position peaked at $749K in Q2 2022.
- 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Patton Albertson Miller Group's 13F filing for Q2 2026, filed 22 Jul 2026.